Medical News

RSS

The E3 Advantage educational healthcare webcast series to be sponsored by MEBS

MEBS, a leading provider of employee benefit services announced its sponsorship of the healthcare webcast series, “The E3 Advantage.” The next webcast will be on November 4th at 2 p.m. ET with the topic, “Looking into the Future of Healthcare” including “The Future of Pharmacy” presented by CVS Caremark. To attend, register at www.mebs.com.

22 Oct 2009

FMWC partners with SOGC and SCC to launch Pap test campaign

The Federation of Medical Women of Canada (FMWC) has joined forces with the Society of Obstetricians and Gynaecologists of Canada (SOGC) and the Society of Canadian Colposcopists (SCC) to launch this year's Pap test campaign during Cervical Cancer Awareness Week. Together, we hope to increase the scope, reach and impact of the campaign. With this collaborative effort, we aim to provide more Pap tests and deal with abnormal results in a more expeditious manner.

22 Oct 2009

Free webinar to help people with written expression deficits

Two experts who specialize in empowering families and professionals with the knowledge of affordable technologies to maximize success are offering a free webinar about resources to support people who have written expression deficits.

22 Oct 2009

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

Applied Biosystems, part of Life Technologies Corporation, today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use.

22 Oct 2009

AdvancedMD Software in Inc. 5000 list of America's fastest growing, privately-held companies

AdvancedMD® Software, Inc., a leader in web-based practice management, billing and EMR applications for medical practices and medical billing services, today announced that for the third consecutive year the company has been named to the prestigious Inc. 5000 list of America's fastest growing, privately-held companies.

22 Oct 2009

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), announced today that clinicians will present a total of 20 clinical posters featuring its Negative Pressure Wound Therapy (NPWT) Systems and ALLEVYN(TM) AG, ALLEVYN AG Gentle, ACTICOAT(TM) and IODOSORB(TM) advanced wound dressings during the 24th Annual Clinical Symposium on Advances in Skin and Wound Care's poster session. The poster session opens at 10:30am CT on October 23, 2009.

22 Oct 2009

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.

22 Oct 2009

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics’ three currently available diagnostic tests.

22 Oct 2009

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

Progenika to provide blood group genotyping reference laboratory services to ARUP

Progenika, Inc. today announced that it has entered into an agreement with ARUP Laboratories (ARUP) of Salt Lake City, UT, to provide blood group genotyping reference laboratory services to ARUP to determine patient red blood cell antigen profiles when serology has logistic and functional limitations.

22 Oct 2009

Merge Healthcare's strategy to expand in China, to take part in China International Medical Equipment Fair

As a part of its ongoing strategic objective of expansion in China, Merge Healthcare (NASDAQ: MRGE) will be exhibiting at the China International Medical Equipment Fair, which will be held at the Chengdu Century City New International Convention & Exhibition Center, October 28 - 31, 2009.

22 Oct 2009

Antiviral prescriptions at retail pharmacies increase by 36% in one week

SDI’s Vector One®: National shows that for the week ending Oct. 16, the number of antiviral prescriptions dispensed at retail pharmacies was 36% higher than the prior week.

22 Oct 2009

Mead Johnson announces its financial results for the third quarter ended Sept. 30, 2009

Mead Johnson Nutrition Company announced today its financial results for the third quarter ended Sept. 30, 2009.

22 Oct 2009

First-quarter fiscal 2010 results announced by Kensey Nash

Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its first quarter ended September 30, 2009.

22 Oct 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb Company today reported strong sales and earnings growth for the third quarter 2009.

22 Oct 2009

Celgene announces fiscal 2009 third-quarter results

Celgene Corporation announced non-GAAP (Generally Accepted Accounting Principles) net income of $259.8 million, or non-GAAP earnings per diluted share of $0.56 for the quarter ended September 30, 2009. Non-GAAP net income for the third quarter of 2008 was $185.9 million, or non-GAAP earnings per diluted share of $0.40.

22 Oct 2009

Merck's sales increases by 2% in third quarter 2009

Merck & Co., Inc. today announced financial results for the third quarter of 2009. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the quarter of $0.90, which excludes a $1.7 billion after-tax gain from the sale of the company's interest in Merial Limited as well as restructuring charges and pre-closing merger-related expenses. Third-quarter GAAP EPS was $1.61.

22 Oct 2009

NCI implements NanoString Technologies' nCounter Analysis System

NanoString Technologies, Inc., a privately held life sciences company marketing a molecular barcoding detection system, today announced that the National Cancer Institute (NCI) is employing its nCounter™ Analysis System at two of its core labs.

From NanoString Technologies 22 Oct 2009

Illegal residents' view on healthcare status

The dissertation focuses on how individual non-citizens residing illegally in the country perceive their health status, what wishes they have regarding healthcare, and whether these wishes are fulfilled. The individual perspective is used instead of the more common concepts of health and healthcare needs, which are based more on the care-giver perspective.

22 Oct 2009

Helix Hearing Care Centre's initiative to increase hearing healthcare awareness

Helix Hearing Care Centre, a subsidiary of Lifestyle Hearing Corporation, has recently signed a sponsorship agreement with the Ottawa Senators. They are now the Official Hearing Care Company of one of Canada's most-loved hockey teams.

22 Oct 2009

Medical News

The E3 Advantage educational healthcare webcast series to be sponsored by MEBS

FMWC partners with SOGC and SCC to launch Pap test campaign

Free webinar to help people with written expression deficits

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

AdvancedMD Software in Inc. 5000 list of America's fastest growing, privately-held companies

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Rosetta Genomics, GTG sign exclusive distribution agreement

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Progenika to provide blood group genotyping reference laboratory services to ARUP

Merge Healthcare's strategy to expand in China, to take part in China International Medical Equipment Fair

Antiviral prescriptions at retail pharmacies increase by 36% in one week

Mead Johnson announces its financial results for the third quarter ended Sept. 30, 2009

First-quarter fiscal 2010 results announced by Kensey Nash

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Celgene announces fiscal 2009 third-quarter results

Merck's sales increases by 2% in third quarter 2009

NCI implements NanoString Technologies' nCounter Analysis System

Illegal residents' view on healthcare status

Helix Hearing Care Centre's initiative to increase hearing healthcare awareness

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News